🔗 Share this article

The prestigious award in medical science was granted for revolutionary findings that clarify how the immune system attacks dangerous infections while sparing the body's own cells.

A trio of esteemed scientists—from Japan Prof. Sakaguchi and American scientists Dr. Brunkow and Fred Ramsdell—received this honor.

Their research identified unique "sentinels" within the immune system that eliminate malfunctioning defense cells that could harming the body.

The findings are now paving the way for new therapies for immune disorders and malignancies.

These laureates will divide a monetary award worth 11 million SEK.

Crucial Discoveries

"The work has been essential for comprehending how the immune system functions and the reason we don't all suffer from serious self-attack conditions," commented the chair of the Nobel Committee.

This team's studies address a core question: How does the immune system protect us from countless invaders while leaving our healthy cells intact?

The immune system uses immune cells that scan for indicators of infection, even pathogens and bacteria it has not met before.

These defenders utilize detectors—known as recognition units—that are produced randomly in a vast number of combinations.

That gives the defense network the capacity to combat a wide array of threats, but the randomness of the mechanism inevitably creates white blood cells that may attack the host.

Security Guards of the Body

Researchers earlier knew that a portion of these problematic defense cells were destroyed in the immune organ—the site where immune cells develop.

The latest Nobel Prize honors the identification of T-reg cells—described as the immune system's "peacekeepers"—which patrol the body to neutralize other immune cells that assault the healthy cells.

It is known that this mechanism fails in autoimmune diseases such as type-1 diabetes, MS, and RA.

A Nobel panel stated, "The findings have established a new field of research and accelerated the creation of new treatments, for instance for cancer and autoimmune diseases."

Regarding malignancies, T-regs prevent the body from attacking the growth, so research are focused on lowering their quantity.

In autoimmune diseases, experiments are exploring increasing regulatory T-cells so the organism is no longer being harmed. A similar method could also be effective in reducing the chances of transplanted organ rejection.

Innovative Experiments

Professor Sakaguchi, from Osaka University, performed experiments on rodents that had their immune gland removed, leading to autoimmune disease.

He demonstrated that injecting immune cells from other animals could prevent the illness—suggesting there was a system for preventing immune cells from harming the body.

Dr. Brunkow, from the a research center in a US city, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an genetic autoimmune disease in rodents and humans that led to the discovery of a gene vital for the way regulatory T-cells function.

"The groundbreaking work has uncovered how the body's defenses is kept in check by regulatory T cells, stopping it from mistakenly attacking the body's own tissues," said a leading physiology specialist.

"This work is a striking example of how fundamental physiological research can have far-reaching consequences for public health."